PROG

Progenity Stock Price

0.8908
-0.0092 (-1.02%)
Upgrade to Real-Time
Regular Market
0.8908

Low
0.657

52 Week Range

High
9.56

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Progenity Inc PROG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0092 -1.02% 0.8908 11:15:02
Open Price Low Price High Price Close Price Prev Close
0.9096 0.8655 0.91 0.90
Bid Price Ask Price Spread News
0.8908 0.898 0.0072 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,011 1,789,321 $ 0.8905606 $ 1,593,499 - 0.657 - 9.56
Last Trade Time Type Quantity Stock Price Currency
11:15:02 3,789 $ 0.8908 USD

Period:

Draw Mode:

Progenity Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 106.87M 119.41M 82.29M $ 74.31M $ - -8.71 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 35.44M 13.50%

more financials information »

Progenity News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PROG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.95741.020.86550.92857936,727,995-0.0666-6.96%
1 Month0.781.250.7550.991082914,637,7510.110814.21%
3 Months3.383.380.6571.107,631,959-2.49-73.64%
6 Months4.335.130.6571.494,418,284-3.44-79.43%
1 Year8.829.560.6571.932,503,660-7.93-89.9%
3 Years15.1115.900.6572.071,992,956-14.22-94.1%
5 Years15.1115.900.6572.071,992,956-14.22-94.1%

Progenity Description

Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products as well as innovating in the field of precision medicine. It utilizes a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to molecular testing products and to the development of a suite of investigational ingestible devices and drug and device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing. The company's operations are carried out in the United States.


Your Recent History
NASDAQ
PROG
Progenity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.